Research Groups

Early Detection and Prevention - Prevention and Implementation Group

Previous Publications - All Publications 2016-2012

1. Harari A., Chen Z., Rodriguez A. C., Hildesheim A., Porras C., Herrero R., Wacholder S., Panagiotou O. A., Befano B., Burk R. D., Schiffman M. (2016) Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections Journal of Infectious Diseases; 213(6):939-47. PMID: 26518044

2. Murillo R., Diaz S., Perry F., Poveda C., Pineros M., Sanchez O., Buitrago L., Gamboa O., Lozano T., Yu H., Wang C. Y., Duggan C., Thomas D. B., Anderson B. O. (2016) Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening International Journal of Cancer; 138(3):705-13. PMID: 26264446

3. Hernandez-Avila M., Torres-Ibarra L., Stanley M., Salmeron J., Cruz-Valdez A., Munoz N., Herrero R., Villasenor-Ruiz I. F., Lazcano-Ponce E. (2016) Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes Human Vaccines & Immunotherapeutics; 12(1):30-8. PMID: 26211489

4. Beachler D. C., Kreimer A. R., Schiffman M., Herrero R., Wacholder S., Rodriguez A. C., Lowy D. R., Porras C., Schiller J. T., Quint W., Jimenez S., Safaeian M., Struijk L., Schussler J., Hildesheim A., Gonzalez P. (2016) Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection Journal of the National Cancer Institute; 108(1):. PMID: 26467666

5. Villain P., Gonzalez P., Almonte M., Franceschi S., Dillner J., Anttila A., Park J. Y., De Vuyst H., Herrero R. (2015) European Code against Cancer 4th Edition: Infections and Cancer Cancer Epidemiology; S120-38. PMID: 26589774

6. Schuz J., Espina C., Villain P., Herrero R., Leon M. E., Minozzi S., Romieu I., Segnan N., Wardle J., Wiseman M., Belardelli F., Bettcher D., Cavalli F., Galea G., Lenoir G., Martin-Moreno J. M., Nicula F. A., Olsen J. H., Patnick J., Primic-Zakelj M., Puska P., van Leeuwen F. E., Wiestler O., Zatonski W. (2015) European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk Cancer Epidemiology; S1-10. PMID: 26164654

7. Minozzi S., Armaroli P., Espina C., Villain P., Wiseman M., Schuz J., Segnan N. (2015) European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations Cancer Epidemiology; S11-9. PMID: 26439654

8. Armaroli P., Villain P., Suonio E., Almonte M., Anttila A., Atkin W. S., Dean P. B., de Koning H. J., Dillner L., Herrero R., Kuipers E. J., Lansdorp-Vogelaar I., Minozzi S., Paci E., Regula J., Tornberg S., Segnan N. (2015) European Code against Cancer, 4th Edition: Cancer screening Cancer Epidemiology; S139-52. PMID: 26596722

9. Shimakawa Y., Lemoine M., Bottomley C., Njai H. F., Ndow G., Jatta A., Tamba S., Bojang L., Taal M., Nyan O., D'Alessandro U., Njie R., Thursz M., Hall A. J. (2015) Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia Liver Int; 35(10):2318-26. PMID: 25728498

10. Bryant D., Hibbitts S., Almonte M., Tristram A., Fiander A., Powell N. (2015) Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women Journal of Clinical Virology; 66-71. PMID: 25866341

11. (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination ; 22-31.

12. Toporcov T.N., Znaor A., Zhang Z.F., Yu G.P., Winn D.M., Wei Q., Vilensky M., Vaughan T., Thomson P., Talamini R., Szeszenia-Dabrowska N., Sturgis E.M., Smith E., Shangina O., Schwartz S.M., Schantz S., Rudnai P., Richiardi L., Ramroth H., Purdue M.P., Olshan A.F., Eluf-Neto J., Muscat J., Moyses R.A., Morgenstern H., Menezes A., McClean M., Matsuo K., Mates D., Macfarlane T.V., Lissowska J., Levi F., Lazarus P., La Vecchia C., Lagiou P., Koifman S., Kjaerheim K., Kelsey K., Holcatova I., Herrero R., Healy C., Hayes R.B., Franceschi S., Fernandez L., Fabianova E., Daudt A.W., Curioni O.A., Maso L.D., Curado M.P., Conway D.I., Chen C., Castellsague X., Canova C., Cadoni G., Brennan P., Boccia S., Antunes J.L., Ahrens W., Agudo A., Boffetta P., Hashibe M., Lee Y.C., Filho V.W. (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium ; 44(1):169-185.

13. Quesada P., Whitby D., Benavente Y., Miley W., Labo N., Chichareon S., Trong N., Shin H.R., Anh P.T., Thomas J., Matos E., Herrero R., Munoz N., Molano M., Franceschi S., de Sanjose S. (2015) Hepatitis C virus seroprevalence in the general female population from 8 countries J Clin. Virol; 89-93.

14. Porras C., Hildesheim A., Gonzalez P., Schiffman M., Rodriguez A.C., Wacholder S., Jimenez S., Quint W., Guillen D., Kreimer A.R., Herrero R. (2015) Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing Journal of the National Cancer Institute; 107(1):400. PMID: 25479804

15. Park M.K., Park J.Y., Nicolas G., Paik H.Y., Kim J., Slimani N. (2015) Adapting a standardised international 24 h dietary recall methodology (GloboDiet software) for research and dietary surveillance in Korea ; 113(11):1810-1818. PMID: 25899045

16. Panagiotou O.A., Befano B.L., Gonzalez P., Rodriguez A.C., Herrero R., Schiller J.T., Kreimer A.R., Schiffman M., Hildesheim A., Wilcox A.J., Wacholder S. (2015) Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial BMJ; h4358.

17. Lowy D.R., Herrero R., Hildesheim A., Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials (2015) Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging Lancet Oncology; 16(5):e226-e233. PMID: 25943067

18. Kreimer A.R., Struyf F., Del Rosario-Raymundo M.R., Hildesheim A., Skinner S.R., Wacholder S., Garland S.M., Herrero R., David M.P., Wheeler C.M. (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials Lancet Oncology; 16(7):775-786. PMID: 26071347

19. Herrero R., Gonzalez P., Markowitz L.E. (2015) Present status of human papillomavirus vaccine development and implementation Lancet Oncology; 16(5):e206-e216. PMID: 25943065

20. Gonzalez P., Hildesheim A., Herrero R., Katki H., Wacholder S., Porras C., Safaeian M., Jimenez S., Darragh T.M., Cortes B., Befano B., Schiffman M., Carvajal L., Palefsky J., Schiller J., Ocampo R., Schussler J., Lowy D., Guillen D., Stoler M.H., Quint W., Morales J., Avila C., Rodriguez A.C., Kreimer A.R. (2015) Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica Vaccine; 33(18):2141-2151. PMID: 25796338

21. de Batlle J., Ferrari P., Chajes V., Park J.Y., Slimani N., McKenzie F., Overvad K., Roswall N., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Fagherazzi G., Katzke V., Kaaks R., Bergmann M.M., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Sieri S., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., Peeters P.H., Hjartaker A., Engeset D., Weiderpass E., Sanchez S., Travier N., Sanchez M.J., Amiano P., Chirlaque M.D., Barricarte Gurrea A., Khaw K.T., Key T.J., Bradbury K.E., Ericson U., Sonestedt E., Van Guelpen B., Schneede J., Riboli E., Romieu I. (2015) Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutrition Journal of the National Cancer Institute; 107(1):367. PMID: 25505228

22. Conway D.I., Brenner D.R., McMahon A.D., Macpherson L.M., Agudo A., Ahrens W., Bosetti C., Brenner H., Castellsague X., Chen C., Curado M.P., Curioni O.A., Dal Maso L., Daudt A.W., de Gois Filho J.F., D'Souza G., Edefonti V., Fabianova E., Fernandez L., Franceschi S., Gillison M., Hayes R.B., Healy C.M., Herrero R., Holcatova I., Jayaprakash V., Kelsey K., Kjaerheim K., Koifman S., La Vecchia C., Lagiou P., Lazarus P., Levi F., Lissowska J., Luce D., Macfarlane T.V., Mates D., Matos E., McClean M., Menezes A.M., Menvielle G., Merletti F., Morgenstern H., Moysich K., Muller H., Muscat J., Olshan A.F., Purdue M.P., Ramroth H., Richiardi L., Rudnai P., Schantz S., Schwartz S.M., Shangina O., Simonato L., Smith E., Stucker I., Sturgis E.M., Szeszenia-Dabrowska N., Talamini R., Thomson P., Vaughan T.L., Wei Q., Winn D.M., Wunsch-Filho V., Yu G.P., Zhang Z.F., Zheng T., Znaor A., Boffetta P., Chuang S.C., Ghodrat M., Amy Lee Y.C., Hashibe M., Brennan P. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries International Journal of Cancer; 136(5):1125-1139. PMID: 24996155

23. Arrossi S., Thouyaret L., Laudi R., Marin O., Ramirez J., Paolino M., Herrero R., Campanera A. (2015) Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina Int. J Cancer; 137(7):1709-1718.

24. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial ; 3(2):e85-e94. PMID: 25617202

25. Antilla A., Arbyn M, De Vuyst H., Dillner J., Dillner L., Franceschi S., Patnick J., Ronco G., Segnan N., Suonio E., Tornberg S., von Karsa L. (2015) European guidelines for quality assurance in cervical cancer screening ; .

26. Almonte M., Ferreccio C., Luciani S., Gonzales M., Delgado J.M., Santos C., Alvarez M., Cuzick J., Sasieni P. (2015) Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru ; 10(1):e0115355.

27. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., Kitchener H., Segnan N., Gilham C., Giorgi-Rossi P., Berkhof J., Peto J., Meijer C.J. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet; 383(9916):524-532.

28. Rollan A., Arab J.P., Camargo M.C., Candia R., Harris P., Ferreccio C., Rabkin C.S., Gana J.C., Cortes P., Herrero R., Duran L., Garcia A., Toledo C., Espino A., Lustig N., Sarfatis A., Figueroa C., Torres J., Riquelme A. (2014) Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus World Journal of Gastroenterology; 20(31):10969-10983.

29. Robbins H.A., Waterboer T., Porras C., Kemp T.J., Pawlita M., Rodriguez A.C., Wacholder S., Gonzalez P., Schiller J.T., Lowy D.R., Esser M., Matys K., Poncelet S., Herrero R., Hildesheim A., Pinto L.A., Safaeian M. (2014) Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay ; 10(10):2965-2974.

30. Robbins H.A., Li Y., Porras C., Pawlita M., Ghosh A., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Gonzalez P., Schiller J., Lowy D., Esser M., Matys K., Quint W., Van Doorn L.J., Herrero R., Pinto L.A., Hildesheim A., Waterboer T., Safaeian M. (2014) Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus ; 120.

31. Robbins H.A., Kemp T.J., Porras C., Rodriguez A.C., Schiffman M., Wacholder S., Gonzalez P., Schiller J., Lowy D., Poncelet S., Esser M., Matys K., Hildesheim A., Pinto L.A., Herrero R., Safaeian M. (2014) Comparison of antibody responses to human papillomavirus vaccination as measured by three assays Frontiers in Oncology; 328.

32. Park J.Y., von Karsa L., Herrero R. (2014) Prevention strategies for gastric cancer: a global perspective ; 47(6):478-489.

33. Leoncini E., Ricciardi W., Cadoni G., Arzani D., Petrelli L., Paludetti G., Brennan P., Luce D., Stucker I., Matsuo K., Talamini R., La Vecchia C., Olshan A.F., Winn D.M., Herrero R., Franceschi S., Castellsague X., Muscat J., Morgenstern H., Zhang Z.F., Levi F., Dal Maso L., Kelsey K., McClean M., Vaughan T.L., Lazarus P., Purdue M.P., Hayes R.B., Chen C., Schwartz S.M., Shangina O., Koifman S., Ahrens W., Matos E., Lagiou P., Lissowska J., Szeszenia-Dabrowska N., Fernandez L., Menezes A., Agudo A., Daudt A.W., Richiardi L., Kjaerheim K., Mates D., Betka J., Yu G.P., Schantz S., Simonato L., Brenner H., Conway D.I., Macfarlane T.V., Thomson P., Fabianova E., Znaor A., Rudnai P., Healy C., Boffetta P., Chuang S.C., Lee Y.C., Hashibe M., Boccia S. (2014) Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium European Journal of Epidemiology; 29(1):35-48.

34. Lazcano-Ponce E., Stanley M., Munoz N., Torres L., Cruz-Valdez A., Salmeron J., Rojas R., Herrero R., Hernandez-Avila M. (2014) Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine; 32(6):725-732.

35. Lang Kuhs K.A., Porras C., Schiller J.T., Rodriguez A.C., Schiffman M., Gonzalez P., Wacholder S., Ghosh A., Li Y., Lowy D.R., Kreimer A.R., Poncelet S., Schussler J., Quint W., Van Doorn L.J., Sherman M.E., Sidawy M., Herrero R., Hildesheim A., Safaeian M. (2014) Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates ; 180(6):599-607.

36. Lang Kuhs K.A., Gonzalez P., Rodriguez A.C., Van Doorn L.J., Schiffman M., Struijk L., Chen S., Quint W., Lowy D.R., Porras C., DelVecchio C., Jimenez S., Safaeian M., Schiller J.T., Wacholder S., Herrero R., Hildesheim A., Kreimer A.R. (2014) Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial Journal of Infectious Diseases; 210(12):1890-1899.

37. Herrero R., Parsonnet J., Greenberg E.R. (2014) Prevention of gastric cancer JAMA; 312(12):1197-1198.

38. Herrero R., Park J.Y., Forman D. (2014) The fight against gastric cancer - the IARC Working Group report ; 28(6):1107-1114.

39. Guevara E., Baena A., Almonte M., Salaza J.E., Gaviria A., Sanchez G.I. (2014) ; 32(2):54-60.

40. De Vuyst H., Mugo N.R., Franceschi S., McKenzie K., Tenet V., Njoroge J., Rana F.S., Sakr S.R., Snijders P.J., Chung M.H. (2014) Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya PloS One; 9(10):e111037.

41. Combes J.D., Pawlita M., Waterboer T., Hammouda D., Rajkumar T., Vanhems P., Snijders P., Herrero R., Franceschi S., Clifford G. (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer International Journal of Cancer; 135(10):2453-2461.

42. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. (2014) Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer Virology; 356-362.

43. Campos N.G., Burger E.A., Sy S., Sharma M., Schiffman M., Rodriguez A.C., Hildesheim A., Herrero R., Kim J.J. (2014) An updated natural history model of cervical cancer: derivation of model parameters American Journal of Epidemiology; 180(5):545-555.

44. Bedoya A.M., Tate D.J., Baena A., Cordoba C.M., Borrero M., Pareja R., Rojas F., Patterson J.R., Herrero R., Zea A.H., Sanchez G.I. (2014) Immunosuppression in cervical cancer with special reference to arginase activity ; 135(1):74-80.

45. Anantharaman D., Chabrier A., Gaborieau V., Franceschi S., Herrero R., Rajkumar T., Samant T., Mahimkar M.B., Brennan P., McKay J.D. (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India PloS One; 9(2):e88240.

46. Torres J., Correa P., Ferreccio C., Hernandez-Suarez G., Herrero R., Cavazza-Porro M., Dominguez R., Morgan D. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America Cancer Causes and Control; 24(2):249-256.

47. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., Lowy D.R., Wacholder S., Schiffman M., Rodriguez A.C., Herrero R., Kemp T., Shelton G., Quint W., Van Doorn L.J., Hildesheim A., Pinto L.A. (2013) Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the costa rica vaccine trial ; 6(11):1242-1250.

48. Safaeian M., Kemp T.J., Pan D.Y., Porras C., Rodriguez A.C., Schiffman M., Cortes B., Katki H., Wacholder S., Schiller J.T., Gonzalez P., Penrose K., Lowy D.R., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Pinto L.A. (2013) Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial ; 9(7):1399-1406.

49. Rodriguez A.C., Solomon D., Herrero R., Hildesheim A., Gonzalez P., Wacholder S., Porras C., Jimenez S., Schiffman M. (2013) Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment ; 178(5):752-760.

50. Porras C., Nodora J., Sexton R., Ferreccio C., Jimenez S., Dominguez R.L., Cook P., Anderson G., Morgan D.R., Baker L.H., Greenberg E.R., Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) Cancer Causes and Control; 24(2):209-215.

51. Park J.Y., Forman D., Greenberg E.R., Herrero R. (2013) Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? Current Oncology Reports; 15(6):517-525.

52. Nascimento C., De Vuyst H. (2013) Prevalence and type distribution of HPV in carcinoma and intraepithelial neoplasia of the vulva and vagina: a meta-analysis ; 12-13.

53. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586.

54. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. (2013) HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays PloS One; 8(1):e53067.

55. Lang Kuhs K.A., Gonzalez P., Struijk L., Castro F., Hildesheim A., Van Doorn L.J., Rodriguez A.C., Schiffman M., Quint W., Lowy D.R., Porras C., DelVecchio C., Katki H.A., Jimenez S., Safaeian M., Schiller J., Solomon D., Wacholder S., Herrero R., Kreimer A.R. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica ; 208(10):1643-1652.

56. Herrero R., Quint W., Hildesheim A., Gonzalez P., Struijk L., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Wacholder S., Kreimer A.R. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PloS One; 8(7):e68329.

57. Herrero R. (2013) HPV and Cervical Cancer ; .

58. De Vuyst H., Chung M.H., Baussano I., Mugo N.R., Tenet V., van Kemenade F.J., Rana F.S., Sakr S.R., Meijer C.J., Snijders P.J., Franceschi S. (2013) Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya Int. J Cancer; 133(6):1441-1446.

59. Bedoya A.M., Jaramillo R., Baena A., Castano J., Olaya N., Zea A.H., Herrero R., Sanchez G.I. (2013) Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer Cancer Microenvironment; 6(1):69-77.

60. Santesso N., Schunemann H., Blumenthal P., De Vuyst H., Gage J., Garcia F., Jeronimo J., Lu R., Luciani S., Quek S.C., Awad T., Broutet N. (2012) World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia International Journal of Gynaecology and Obstetrics; 118(2):97-102.

61. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., Van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. (2012) Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials Cancer Epidemiology, Biomarkers and Prevention; 21(9):1547-1554.

62. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Cheung L., Wacholder S., Burk R.D. (2012) Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3 International Journal of Cancer; 131(8):1874-1881.

63. Li Q., Chuang S.C., Eluf-Neto J., Menezes A., Matos E., Koifman S., Wunsch-Filho V., Fernandez L., Daudt A.W., Curado M.P., Winn D.M., Franceschi S., Herrero R., Castellsague X., Morgenstern H., Zhang Z.F., Lazarus P., Muscat J., McClean M., Kelsey K.T., Hayes R.B., Purdue M.P., Schwartz S.M., Chen C., Benhamou S., Olshan A.F., Yu G., Schantz S., Ferro G., Brennan P., Boffetta P., Hashibe M. (2012) Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium International Journal of Cancer; 131(7):1686-1699.

64. Kreimer A.R., Schiffman M., Herrero R., Hildesheim A., Gonzalez P., Burk R.D., Porras C., Sherman M.E., Demuth F., Cheung L., Bratti C., Cecilia Rodriguez A. (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment International Journal of Cancer; 131(1):211-218.

65. Kemp T.J., Safaeian M., Miner S., Williams M.C., Rodriguez A.C., Herrero R., Hildesheim A., Pinto L.A. (2012) Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels Frontiers in Oncology; 61.

66. Kemp T.J., Safaeian M., Hildesheim A., Pan Y., Penrose K.J., Porras C., Schiller J.T., Lowy D.R., Herrero R., Pinto L.A. (2012) Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix((R)) Vaccine; 31(1):165-170.

67. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. (2012) Evaluation of the FTA carrier device for human papillomavirus testing in developing countries Journal of Clinical Microbiology; 50(12):3870-3876.

68. Castro F.A., Quint W., Gonzalez P., Katki H.A., Herrero R., Van Doorn L.J., Schiffman M., Struijk L., Rodriguez A.C., Del Vecchio C., Lowy D.R., Porras C., Jimenez S., Schiller J., Solomon D., Wacholder S., Hildesheim A., Kreimer A.R. (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica Journal of Infectious Diseases; 206(7):1103-1110.